Basilea Pharmaceutica AG (BPMUF)
OTCMKTS · Delayed Price · Currency is USD
67.75
+6.41 (10.45%)
At close: Jul 30, 2025
Basilea Pharmaceutica AG Employees
Basilea Pharmaceutica AG had 164 employees as of December 31, 2024. The number of employees increased by 17 or 11.56% compared to the previous year.
Employees
164
Change (1Y)
17
Growth (1Y)
11.56%
Revenue / Employee
$1,650,083
Profits / Employee
$507,564
Market Cap
700.79M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 164 | 17 | 11.56% |
| Dec 31, 2023 | 147 | 6 | 4.26% |
| Dec 31, 2022 | 141 | -13 | -8.44% |
| Dec 31, 2021 | 154 | -3 | -1.91% |
| Dec 31, 2020 | 157 | -68 | -30.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Tian'an Technology Group | 8 |
| Glass House Brands | 374 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
| Longduoduo Company | 49 |
Basilea Pharmaceutica AG News
- 4 months ago - Assessment of the 14-Alpha Demethylase Inhibitors Pipeline Landscape 2025, Featuring Insights Into Oteseconazole (Mycovia Pharmaceuticals) and Isavuconazonium (Basilea Pharmaceutica) - GlobeNewsWire
- 4 months ago - Strong sales for Cresemba® (isavuconazole) in Japan trigger second milestone payment from Asahi Kasei Pharma to Basilea - GlobeNewsWire
- 7 months ago - Basilea Pharmaceutica Ltd (XSWX:BSLN) Full Year 2024 Earnings Call Highlights: A Year of Robust ... - GuruFocus
- 7 months ago - Full Year 2024 Basilea Pharmaceutica AG Allschwil Earnings Call Transcript - GuruFocus
- 7 months ago - Basilea projects CHF220M in 2025 revenue with key pipeline advancements and U.S. launch of Zevtera - Seeking Alpha
- 7 months ago - Basilea Pharmaceutica AG (BPMUF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 months ago - Basilea Pharmaceutica AG 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 7 months ago - Basilea Pharmaceutica GAAP EPS of CHF5.83, revenue of CHF208.5M; initiates FY25 outlook - Seeking Alpha